Present in 63 of 295 (21.4%, Table-2 and Figure-2A-2C), CEBPD amplification strongly correlated with CEBPD immunohistochemical overexpression (Figure-2D-2F), and both preferentially appeared in cases with more advanced primary tumor (pT) and nodal status (N), as well as in those with higher histological grade, vascular invasion, and higher mitotic activity (Table-2). This evidence concerns the gene CEBPD and neoplasm.